What's breaking now, across thousands of outlets.
Boehringer Ingelheim will seek approval for its incretin shot survodutide for obesity next year, after a trial showed that the drug doesn’t increase patients’ risk of cardiovascular events like heart attacks and strokes. If the ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The week began with one of the biggest fuel price drops in Portugal since March, 9 to 9.5 cents on petrol and diesel, but it would have been bigger had the government not reduced the ISP discount.
Morgan Stanley has struck a deal to buy Vinyl Equity, a digital-first SEC-registered transfer agent and shareholder recordkeeping platform. Terms of the deal were not disclosed.
An AI-driven bull market means a heavy tech bias at an index level.
Lower middle market bets and a collateral sale headline this quarter's update.
High-yield dividend stocks can burn your portfolio, but these blue chip stocks stand out.
The loss of his Republican Party majority to the Democratic Party in the U.S. Senate and the House of Representatives in the 2026 U.S.
